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Background: To examine the effects of intravenous sedation and oral nifedipine on blood pressure and pulse rate in
patients with perioperative high blood pressure undergoing implant surgery, the clinical records of dental implant
patients managed by intravenous sedation at our outpatient dental offices were retrospectively evaluated.
Methods: A total of 516 clinical charts were evaluated. The subjects were divided into two groups: a normotensive group
with no history of hypertension and a hypertensive group with a history of hypertension. The patients in the hypertensive
group were further divided into two subgroups: with or without nifedipine administration before operation. Systolic
blood pressure (SBP), diastolic blood pressure (DBP), pulse rate (PR), and rate pressure product (RPP) were assessed.
Results: In 30 patients (33%) of the hypertensive group, the high blood pressure on arrival obviously declined to around
or less than 160 mmHg; in the remaining patients in the group who showed a mean SBP of 182.1 ± 13.8 mmHg on
arrival, the blood pressure did not decrease after a 30-min rest. Oral nifedipine administered to the patients with sustained
high blood pressure decreased SBP to 144.7 ± 23.1 mmHg in 28.1 ± 9.3 min after administration, comparable to that in
hypertensive patients without nifedipine.
Conclusions: For patients with stage 2 hypertension before operation, it may be difficult to maintain the recommended
blood pressure during surgery by only intravenous sedation; reduction of blood pressure by antihypertensive drugs may
be necessary.
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Osseointegrated dental implants were introduced in
Japan in 1983, and the procedures are now performed
very frequently. Dental implants are placed in a wide age
range of patients, including elderly patients with hyper-
tension. Patients with very high blood pressure are at
great risk for acute medical problems when undergoing
stressful dental procedures, such as oral surgery, peri-
odontal surgery, and placement of dental implants [1].
Patients with normal blood pressure (<120/80 mmHg),
prehypertension (120 to 139/80 to 89 mmHg), or stage I
hypertension (140 to 159/90 to 99 mmHg) may receive* Correspondence: kimkimkim0719@yahoo.co.jp
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in any medium, provided the original work is pregular dental care, but those with stage 2 hypertension
(≥160/≥100 mmHg) should receive noninvasive treatment
only and be referred to the physician for immediate
follow-up [2]. Normotensive individuals may develop signs
of hypertensive encephalopathy at blood pressures as low
as 160/100 mmHg, whereas chronically hypertensive pa-
tients can tolerate higher blood pressure and may not do
so until the blood pressure rises to 220/110 mmHg or
above [3]. Although no recommendation has been pre-
sented on the optimal level of blood pressure to avoid
hypertensive complications during invasive dental treat-
ments, blood pressure in hypertensive patients should be
maintained below 160/100 mmHg.
Pain, stress, or anxiety-related dental procedures can raise
blood pressure in both hypertensive and normotensivean open access article distributed under the terms of the Creative Commons
g/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction
roperly credited.
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manage patients with hypertension as well as dental anxiety
and phobia. The oral antihypertensive agent nifedipine is
mainly administered to patients with high systolic blood
pressure (SBP) ≥160 mmHg prior to implant placement.
To examine the effects of intravenous sedation and oral ni-
fedipine on blood pressure and pulse rate in patients with
perioperative high blood pressure, the clinical records of
dental implant patients managed by intravenous sedation at
our outpatient dental offices were retrospectively evaluated.
The purpose of this clinical study is to examine whether
intravenous sedation and oral administration of nifedipine
is efficient for the hemodynamic for the patient with hyper-
tension. The authors expect that it is possible not only to
obtain a hemodynamic blood stable but also to prevent the
medical sequelae by performing intravenous sedation and
oral nifedipine for patients with hypertension.
Methods
A retrospective review of the clinical records was con-
ducted for 336 patients who received dental implant-
related surgeries combined with intravenous sedation
between January 2008 and February 2012 at our outpatient
dental offices. Among the patients, 125 patients received
multiple surgeries during the observation period: 4 patients
underwent surgery five times, 7 patients four times, 29 pa-
tients three times, 85 patients twice, and others once. The
following surgical procedures were performed in a total of
516 patients: dental implant placement (466 patients),
sinus lift surgery and dental implant (28 patients), socket
lift and dental implant (10 patients), and guided bone re-
generation and dental implant (12 patients).
We performed surgeries after medical consultation
when patients had a history of hypertension or cardio-
vascular or cerebrovascular diseases. History of ischemic
heart disease, renal dysfunction, diabetes mellitus, cere-
bral infarction, or articular rheumatism was documented
in 17 patients in the hypertensive group and 16 patients
in the normotensive group. They were confirmed stable
and well controlled for implant surgery. For patients
who received therapeutic drugs, surgery was performed
following daily medication.
The patients were allowed to have water or snacks
until 2 h before the visit. On arrival at the office, systolic
blood pressure (SBP), diastolic blood pressure (DBP),
and pulse rate (PR) were measured using an automatic
blood pressure monitor with an oscillometric method
(HEM-1010, Omron Healthcare, Kyoto, Japan). The ceph-
alic vein was cannulated with a 22-G disposable intraven-
ous catheter. Nifedipine capsule (10 mg) was orally
administered to patients with sustained increases in
SBP ≥160 mmHg for 30 min from baseline measurement.
A noninvasive blood pressure monitoring system with elec-
trocardiogram (ECG) monitor and pulse oximeter (MoneoBP-88, Omron Healthcare, Kyoto, Japan) was mounted,
and blood pressure was measured at 2- to 5-min intervals.
In patients with a history of cardiovascular disease, ECG
was continuously monitored. Following confirmation of a
definite decline of blood pressure or SBP <160 mmHg,
infiltration anesthesia and/or conduction anesthesia was
administered using 1 to 3 cartridges (1.8 to 5.4 ml) of 2%
lidocaine containing 1/80,000 epinephrine.
Following confirmation of a sufficient anesthetic effect,
intravenous sedation with continuous infusion of propofol
1 to 2 mg/kg/h and midazolam 20 to 40 μg/kg bolus to-
gether with inhalation of oxygen 3 L/min via nasal can-
nula was initiated. After confirming Verrill sign, implant
surgery was initiated. During operation, the propofol dose
was adjusted to maintain the optimum conscious sedative
condition (level 2 on the Ramsay sedation scale) [5], and
local anesthesia was added when the patient complained
of pain. On completion of surgery, administration of oxy-
gen and propofol were terminated and the patient was ob-
served for about 1 h, until normal cognitive and motor
functions were restored.
The subjects were divided into two groups: a normo-
tensive group with no history of hypertension and a
hypertensive group with a history of hypertension. Thir-
teen patients who had no history of hypertension were
included in the hypertensive group, since they indicated
SBP ≥160 mmHg on arrival at the office and were later
diagnosed with essential hypertension by cardiologists.
Furthermore, the patients in the hypertensive group
were divided into two subgroups: with or without nifedi-
pine administration.
From the clinical chart, data of SBP, DBP, PR, and per-
cutaneous oxygen saturation (SpO2) were sampled at the
point of arrival to the office, prior to the initiation of
sedation, 30 min after the initiation of operation, and on
completion of operation. Furthermore, rate pressure
product (RPP: SBP × PR) was calculated.
There were two primary outcome measures: (1) inci-
dence of improved hypertension following oral nifedipine
and (2) incidence of normal ranges of hemodynamic pa-
rameters during surgery. The secondary outcome variable
was incidence of hypertension related to perioperative
complications.
Statistical analysis
In this study, we used data from all cases (516 cases) for
statistical analysis.
Data were described as mean ± standard deviation. The
unpaired t test was used to compare demographic variables
between groups. Fisher's exact test was used to compare ra-
tios of patients in hypertensive group between subgroups.
One-way analysis of variance (ANOVA) followed by Tukey's
multiple comparison test was performed to examine the
change in the values of parameters. Repeated measures
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was used to compare the values of parameters in groups at
each time point. Statistical analysis was performed using
Prism 5 for Windows Ver. 5.01 (GraphPad Software Inc., San
Diego, CA, USA). The significance level was set at p < 0.05.Ethical approval
This study protocol was approved by the ethics committee
of Japanese Dental Society of Anesthesiology (No. 2015–4).Results
Patient demographics and clinical characteristics are sum-
marized in Table 1. There were significant differences in
age (p < 0.0001) and duration of surgery (p = 0.025) be-
tween normotensive and hypertensive groups. On arrival at
the office, values of all hemodynamic parameters, including
SBP, DBP, PR, and RPP, were higher in the hypertensive
group than in the normotensive group (p < 0.0001).
Tables 2 and 3 indicate incidences of patients with
SBP ≥160 mmHg and RPP ≥12,000 bpm×mmHg, and
perioperative hemodynamic changes, respectively. On ar-
rival at the office, 66 patients (62%) in the hypertensive
group and 41 patients (10%) in the normotensive group re-
vealed high SBP ≥160 mmHg. Thirty minutes later, SBP de-
clined to less than 160 mmHg in most of the patients in the
normotensive group. On the other hand, in 30 patients
(33%) in the hypertensive group, high blood pressure on ar-
rival obviously declined to around or less than 160 mmHg,
while in the remaining patients in the group who showed a
mean SBP of 182.1 ± 13.8 mmHg on arrival, the blood pres-
sure did not clearly decrease after 30 min of rest. Oral ni-
fedipine administered to patients with sustained high
blood pressure decreased SBP to 144.7 ± 23.1 mmHg by
28.1 ± 9.3 min after administration, which was similar to
that in hypertensive patients without nifedipine.Table 1 Demographic and clinical characteristics
Normoten
Number (male: female) 410 (127: 2
Age (year mean ± SD) 59 ± 11
Weight (kg) 54.5 ± 9.2
Values of circulation parameters on arrival at office
SBP (mmHg) 133 ± 19
DBP (mmHg) 76 ± 13
PR (bpm) 79 ± 13
RPP (bpm × mmHg) 10,574 ± 2
Preoperative oral nifedipine 0
Duration of surgery (min) 40 ± 20
Duration of sedation (min) 69 ± 25
SBP, systolic blood pressure; DBP, diastolic blood pressure; PR, pulse rate; RPP. rateAlthough the mean SBP in the hypertensive group was
significantly higher than that in the normotensive group
during operation, SBP <160 mmHg was maintained in
all patients except three in the hypertensive group (2.8%)
and one in the normotensive group (0.2%). The values of
DBP in patients in the hypertensive group were higher
than those in the normotensive group throughout the
observation course, and changes in DBP in each group
were similar to those in SBP.
On arrival at the office, RPP ≥12,000 bpm ×mmHg was
found in 74 patients (70%) in the hypertensive group and
111 patients (27%) in the normotensive group. More than
90% of the patients with preoperative nifedipine showed
high RPP on arrival at the office. Among patients with
high RPP, all patients in the normotensive group, 10% of
the patients without nifedipine in the hypertensive group
and 35% of patients with nifedipine in the hypertensive
group had RPP <12,000 bpm×mmHg until initiation of
intravenous sedation. The values of RPP during operation
under intravenous sedation were maintained at a normal
range except in nine patients (8.5%) in the hypertensive
group and one patient (0.2%) in the normotensive group.
In patients with oral nifedipine in the hypertensive
group, the PR value slightly increased prior to initiation
of intravenous sedation (p = 0.224) and then significantly
decreased until completion of the operation (p < 0.001).
All patients stated a pleasant feeling and amnesia during
surgery. No complication occurred during surgery, and no
cognitive and motor dysfunctions were observed 1 h after
surgery. The patients revealed SBP of >160 mmHg during
and at completion of operation showed maximum SBP of
180 mmHg in the normotensive group, 190 mmHg on the
hypertensive group without preoperative oral nifedipine,
and 180 mmHg in the hypertensive group with preopera-
tive oral nifedipine. They did not complaint any symptom
such as headache, confusion, and chest pain. Upon leavingsive group Hypertensive group p value
83) 106 (37: 69) 0.170
65 ± 10 <0.0001
57.1 ± 10.9 0.204
165 ± 22 <0.0001
99 ± 20 <0.0001
90 ± 19 <0.0001
,614 12,367 ± 5,771 <0.0001
44 (42%) <0.0001
35 ± 17 0.025
65 ± 22 0.114
pressure product.
Table 2 Incidence of high blood pressure and high rate pressure product
SBP (>160 mmHg) RPP (>12,000 bpm × mmHg)
Normotensive group (N = 410)
On arrival at the office 41 (10.0%) 111 (27.1%)
Prior to sedation 31 (7.6%) 72 (17.6%)
During operation 1 (0.2%) 1 (0.2%)
Completion of operation 3 (0.7%) 9 (2.2%)
Hypertensive group without preoperative oral nifedipine (N = 62)
On arrival at the office 22 (35.5%)** 34 (54.8%)**
Prior to sedation 13 (21.0%)** 27 (43.5%)**
During operation 2 (3.2%)* 5 (8.1%)**
Completion of operation 5 (8.1%)** 6 (9.7%)**
Hypertensive group with preoperative oral nifedipine (N = 44)
On arrival at the office 44 (100%)** 40 (90.9%)**
Prior to sedation 8 (18.2%)* 24 (54.5%)**
During operation 1 (2.2%) 4 (9.1%)**
Completion of operation 3 (6.8%)* 8 (18.2%)**
*p <0.05, **p <0.01 vs normotensive group (Fisher's exact test). SBP, systolic blood pressure; RPP, rate pressure product.
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on arrival without any antihypertensive treatment.
Discussion
In 44 (8.5%) of the 516 implant surgery cases, oral ni-
fedipine had to be administered, since preoperative SBP
was higher than 160 mmHg in these patients. Within
30 min of administration of nifedipine, SBP of hyperten-
sive patients decreased to a similar range as that of
hypertensive patients who did not need administrationTable 3 Changes in values of hemodynamic parameters
SBP (mmHg) DBP
Normotensive patients (N = 410)
On arrival at the office 133.0 ± 18.4 76.4
Prior to sedation 128.5 ± 18.3* 70.5
During operation 109.7 ± 11.9* 62.7
Completion of operation 115.9 ± 14.2* 66.1
Hypertensive patients without preoperative oral nifedipine (N = 62)
On arrival at the office 152.5 ± 17.6 88.3
Prior to sedation 143.2 ± 18.1* 77.4
During operation 118.9 ± 15.5* 67.2
Completion of operation 125.4 ± 19.1* 68.8
Hypertensive patients with preoperative oral nifedipine (N = 44)
On arrival at the office 182.1 ± 13.8 102.8
Prior to sedation 144.7 ± 23.1* 77.3
During operation 119.8 ± 16.5* 65.8
Completion of operation 130.1 ± 18.8* 71.4
*p <0.01 vs value on arrival at the office (Dunnett's multiple comparison test). SBP,
pressure product.of oral nifedipine. Intravenous sedation after nifedipine
administration to hypertensive patients resulted in stable
hemodynamics during implant surgery.
The Seventh Report of the Joint National Committee on
Prevention, Detection, Evaluation, and Treatment of High
Blood Pressure [6] classified hypertensive patients into five
categories based on systolic or diastolic blood pressure.
Patients with normal blood pressure (<120/80 mmHg),
prehypertension (120 to 139/80 to 89 mmHg), or stage I
hypertension (140 to 159/90 to 99 mmHg) can receive(mmHg) PR (bpm) RPP (bpm × mmHg)
± 12.5 79.2 ± 13.4 10,603 ± 2,623
± 11.9* 76.8 ± 13.0* 9,927 ± 2,485*
± 10.0* 70.6 ± 10.2* 7,768 ± 1,555*
± 11.3* 70.4 ± 10.7* 8,196 ± 1,796*
± 11.8 84.6 ± 14.3 12,972 ± 3,055
± 9.6* 82.7 ± 13.4 11,874 ± 2,540*
± 10.0* 75.2 ± 12.8* 8,977 ± 2,164*
± 12.6* 74.7 ± 10.9* 9,360 ± 1,977*
± 12.5 87.2 ± 17.1 15,901 ± 3,623
± 15.9* 89.3 ± 16.1 12,986 ± 3,437*
± 10.0* 78.0 ± 12.3* 9,413 ± 2,265*
± 13.2* 78.4 ± 13.6* 10,294 ± 2,728*
systolic blood pressure; DBP, diastolic blood pressure; PR, pulse rate; RPP, rate
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necessary for stage I hypertension [2,7]. In accordance with
the guidelines during oral surgery, the blood pressure of
hypertensive patients should be maintained at a normal or
prehypertension level. RPP is a reliable predictor of myo-
cardial oxygen consumption [8], and RPP >12,000 bpm×
mmHg is associated with myocardial ischemia [9,10]. In
this study, although blood pressure was managed by a
physician, hypertensive patients showed SBP >160 mmHg
when they visited the dental office for dental implant
surgery, and 50% of hypertensive patients showed high
RPP after 30 min of rest. In patients presenting with
high blood pressure and high RPP, anxiety and fear must
be reduced by conscious sedation and antihypertensives
to prevent cardiovascular complications during dental
implant surgery.
Increases in SBP due to psychological stress are propor-
tional to age and baseline blood pressure [4]. Intravenous
sedation stabilizes measurable changes in blood pressure
and pulse rate due to fear and anxiety about dental treat-
ment and has been used to manage patients with ischemic
heart disease and hypertension [11]. In this study, the ef-
fect of intravenous sedation was as follows: SBP and RPP,
compared with those prior to intravenous sedation, were
decreased by 15% and 20% in patients with normal blood
pressure, 15% and 25% in hypertensive patients without
oral nifedipine, and 15% to 20% and 20% to 30% in hyper-
tensive patients with administered nifedipine, respectively.
That is, SBP and myocardial oxygen consumption of pre-
hypertension and stage I hypertension can be reduced to
the levels recommended for dental treatment before sur-
gery by intravenous sedation.
For patients with stage 2 hypertension before operation, it
is difficult to maintain the recommended blood pressure
during surgery using only intravenous sedation, and it is ne-
cessary to decrease blood pressure by antihypertensive
drugs. In this study, the blood pressure of patients with sus-
tained hypertension was reduced to stage I hypertension
about 30 min after administration of oral nifedipine. On the
other hand, the decrease in RPP after oral nifedipine admin-
istration was not less than 12,000 bpm×mmHg, which
could be due to the fact that an increase in pulse rate with
nifedipine by reflex tachycardia. Thereafter, blood pressure
and RPP during surgery under intravenous sedation has
remained at levels similar to those of hypertensive patients
with well-controlled blood pressure. Maximum effect (21.4%
decreases in SBP) appears in 30 to 60 min and lasts about
3 h on oral administration of nifedipine [12]. The half-lives
of oral nifedipine, diltiazem and verapamil, and calcium an-
tagonists are 0.2 to 1 h, 6 to 8 h, and 6 to 8 h, respectively
[13]. Since oral nifedipine has the properties of fast onset
(30 to 45 min) [14] and relatively short duration, it is suit-
able for outpatient dental implant surgery and is useful in
perioperative management of patients with hypertension.The overdose of vasoconstrictor that is added to the
local anesthetic in order to prolong the anesthetic effect
and hemostatic action may cause increased blood pres-
sure and arrhythmias. Elevation of blood pressure in
hypertensive patients is greater than that in normoten-
sive patients during dental surgery [15]. Although there
is an increase in blood pressure and tachycardia when
using three cartridges of local anesthetic containing epi-
nephrine 1:10,000 (5.4 ml), there are no adverse symp-
toms in patients with normal blood pressure [16]. Little
recommended that the amount of local anesthetic solu-
tion administered should be less than two cartridges
(3.6 ml) for patients with hypertension [1]. Nakamura
et al. reported that patients with essential hypertension
who have been administered nifedipine can receive less
than 3.6 cartridges of local anesthetic containing epineph-
rine 1:80,000 (6.4 ml) [17]. The administration of exogen-
ous epinephrine with local anesthesia produces the
highest plasma concentration in 3 to 6 min and lasts for
20 min [18]. It has been reported that the anesthetic rate
of 2% lidocaine containing 1:10,000 epinephrine is 47%
45 min after administration and 27% 60 min after admin-
istration [19]. During dental implant surgery which re-
quires a relatively long duration and a wide field in
patients with hypertension, administration of conduction
anesthesia including inferior alveolar block and posterior
superior alveolar nerve block is desirable. When the pa-
tient complains of pain, it is important to add local
anesthesia while monitoring blood pressure to prevent in-
creased blood pressure caused by pain.
Implant surgery is performed in patients with a wide
age range, including elderly patients with hypertension.
Dentists or oral surgeons often encounter hypertensive
patients who are undiagnosed or noncompliant. Among
Japanese over the age of 30, 60% of men and 44.6% of
women suffer from high blood pressure, and 33.8% of
men and 25.6% of women with a history of hypertension
have not been managed medically [20]. In this study,
though 13 of the patients did not have a history of hyper-
tension, they were diagnosed with essential hypertension
by a physician because they had high blood pressure be-
fore surgery. Among patients with a history of high blood
pressure, 31 patients (29%) showed high blood pressure
before surgery. Because there are many of dental patients
with undiagnosed or noncompliant hypertension, blood
pressure measurement before treatment, particularly inva-
sive surgery, is indispensable.
For dental implant surgery in hypertensive patients who
are not adequately controlled, the application of intraven-
ous sedation and preoperative antihypertensive medication
would be useful in order to prevent perioperative hyper-
tension crisis including hypertension emergency with end-
organ damage or hypertension urgency without end-organ
damage. Since sublingual administration of immediate-
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nificant decrease in blood pressure, reflex tachycardia, and
acute myocardial infarction [21], the sublingual adminis-
tration of IR nifedipine to hypertension crisis has not been
approved by the Food and Drug Administration (1985)
and Japanese Society of Hypertension Guidelines for the
Management of Hypertension (2000). Since we could man-
age patients with high blood pressure without any cerebro-
vascular complications by oral administration of nifedipine
under closely monitoring, it may be concluded that pre-
operative administration of oral nifedipine to patients with
high blood pressure may be effective to prevent hypertensive
crisis due to sudden rise in blood pressure during surgery.
Further studies are necessary to evaluate the usefulness of
captopril, clonidine, and labetalol, which have been reported
as alternatives to nifedipine in emergency hypertension
[22-24] in patients with high blood pressure.
Conclusions
In this study, we showed that the stable hemodynamic
was obtained by performing intravenous sedation and oral
administration of nifedipine for patients with hyperten-
sion. It is important not only to understand the systemic
management of the patient but also to obtain stabled
hemodynamic by performing intravenous sedation and
oral administration of nifedipine for patients with hyper-
tension in order to perform the implant surgery safely,
and it could be possible to prevent the medical sequelae.
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